Genetic and Epigenetic Regulation of Organic Cation Transporters.

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Handbook of Experimental Pharmacology

• Publication date

  2021-03-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/164_2021_450PMID 33674913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice.

  2020cited by this paper
• An Interspecies Molecular and Functional Study of Organic Cation Transporters at the Blood-Brain Barrier: From Rodents to Humans

  2020cited by this paper
• The mutational constraint spectrum quantified from variation in 141,456 humans

  2020cited by this paper
• Organic Cation Transporters in Health and Disease

  2020cited by this paper
• Prenatal metformin exposure or organic cation transporter 3 knock‐out curbs social interaction preference in male mice

  2019cited by this paper
• Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

  2019cited by this paper
• Opioids as substrates and inhibitors of the genetically highly variable organic cation transporter OCT1.

  2019cited by this paper
• Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer

  2019cited by this paper
• A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization

  2019cited by this paper
• An unsuspected role for organic cation transporter 3 in the actions of amphetamine

  2018cited by this paper
• Relationship Between SLC22A1 and SLC22A4 Gene Polymorphisms and Risk of Type 2 Diabetes in Chinese Han Population.

  2018cited by this paper
• Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium

  2018cited by this paper
• Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice

  2017cited by this paper
• Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to Children

  2017cited by this paper
• Two unrelated children with overlapping 6q25.3 deletions, motor speech disorders, and language delays

  2017cited by this paper
• The importance of drug transporter characterization to precision medicine

  2017cited by this paper
• Comment on “Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin”

  2017cited by this paper
• Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical Practice.

  2017cited by this paper
• Genetic variation in human drug-related genes

  2017cited by this paper
• OCT1 pharmacogenetics in pain management: is a clinical application within reach?

  2017cited by this paper
• Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma

  2017cited by this paper
• OCT1 mediates hepatic uptake of sumatriptan and loss‐of‐function OCT1 polymorphisms affect sumatriptan pharmacokinetics

  2016cited by this paper
• Ontogeny of Hepatic Drug Transporters as Quantified by LC‐MS/MS Proteomics

  2016cited by this paper
• Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption

  2016cited by this paper
• Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response

  2016cited by this paper
• Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes

  2016cited by this paper
• Localization of organic cation transporter 2 (OCT2) in monoaminergic and cholinergic axon terminals of the mouse brain.

  2016cited by this paper
• DNA Methylation of ADME Genes

  2016cited by this paper
• Decreased Expression of Organic Cation Transporters, Oct1 and Oct2, in Brain Microvessels and its Implication to MPTP-Induced Dopaminergic Toxicity in Aged Mice

  2015cited by this paper
• Tissue-based map of the human proteome

  2015cited by this paper
• Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group

  2015cited by this paper
• Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics

  2015cited by this paper
• Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1

  2015cited by this paper
• A Call for Systematic Research on Solute Carriers.

  2015cited by this paper
• Drug Transporters in the Central Nervous System

  2015cited by this paper
• A Solute Carrier Family 22 Member 3 Variant rs3088442 G→A Associated with Coronary Heart Disease Inhibits Lipopolysaccharide-induced Inflammatory Response*

  2015cited by this paper
• Organic cation transporter variation and response to smoking cessation therapies.

  2014cited by this paper
• Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients

  2014cited by this paper
• Expression and function of organic cation and anion transporters (SLC22 family) in the CNS.

  2014cited by this paper
• Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling

  2014cited by this paper
• PharmGKB summary: very important pharmacogene information for SLC22A1

  2014cited by this paper
• In vitro and in vivo mouse models for pharmacogenetic studies.

  2013cited by this paper
• Organic cation transporter 3 is densely expressed in the intercalated cell groups of the amygdala: anatomical evidence for a stress hormone-sensitive dopamine clearance system.

  2013cited by this paper
• Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2

  2013cited by this paper
• Expression Variability of Absorption, Distribution, Metabolism, Excretion–Related MicroRNAs in Human Liver: Influence of Nongenetic Factors and Association with Gene Expression

  2013cited by this paper
• Omics and drug response.

  2013cited by this paper
• Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events

  2012cited by this paper
• Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens.

  2012cited by this paper
• Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response

  2012cited by this paper
• DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma

  2011cited by this paper
• Genetic and Epigenetic Regulation of the Organic Cation Transporter 3, SLC22A3

  2011cited by this paper
• Possible Association of SLC22A2 Polymorphisms with Aspirin-Intolerant Asthma

  2011cited by this paper
• Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3

  2011cited by this paper
• Evaluation of Genetic Variations in Organic Cationic Transporter 3 in Depressed and Nondepressed Subjects

  2011cited by this paper
• Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.

  2011cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Organic cation transporter inhibition increases medial hypothalamic serotonin under basal conditions and during mild restraint.

  2010cited by this paper
• Repeated Swim Impairs Serotonin Clearance via a Corticosterone-Sensitive Mechanism: Organic Cation Transporter 3, the Smoking Gun

  2010cited by this paper
• Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood‐brain barrier and MPTP‐induced dopaminergic toxicity in rodents

  2010cited by this paper
• Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy.

  2009cited by this paper
• Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease

  2009cited by this paper
• Decreased anxiety in mice lacking the organic cation transporter 3

  2009cited by this paper
• Distribution of organic cation transporter 3, a corticosterone‐sensitive monoamine transporter, in the rat brain

  2009cited by this paper
• Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder.

  2008cited by this paper
• Altered aminergic neurotransmission in the brain of organic cation transporter 3‐deficient mice

  2008cited by this paper
• Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice

  2008cited by this paper
• Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation.

  2008cited by this paper
• Multiple newly identified loci associated with prostate cancer susceptibility

  2008cited by this paper
• Identification of the Endogenous Key Substrates of the Human Organic Cation Transporter OCT2 and Their Implication in Function of Dopaminergic Neurons

  2007cited by this paper
• Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.

  2007cited by this paper
• Epigenetics: A Historical Overview

  2006cited by this paper
• Corticosterone-Sensitive Monoamine Transport in the Rat Dorsomedial Hypothalamus: Potential Role for Organic Cation Transporter 3 in Stress-Induced Modulation of Monoaminergic Neurotransmission

  2006cited by this paper
• Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.

  2006cited by this paper
• Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice.

  2005cited by this paper
• Organic Cation Transporter 3 (Slc22a3) Is Implicated in Salt-Intake Regulation

  2004cited by this paper
• The localisation of the extraneuronal monoamine transporter (EMT) in rat brain

  2003cited by this paper
• Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1

  2003cited by this paper
• Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes

  2002cited by this paper
• Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences.

  2002cited by this paper
• Ventricular Choline Transport

  2001cited by this paper
• Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney.

  2000cited by this paper
• Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.

  1998cited by this paper
• Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter

  1998cited by this paper
• Cloning and Characterization of Two Human Polyspecific Organic Cation Transporters

  1997cited by this paper
• Supplemental Information

  year unknowncited by this paper

• Data- and knowledge-derived functional landscape of human solute carriers

  2024cites this paper
• Structural insights into human organic cation transporter 1 transport and inhibition

  2024cites this paper
• Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin

  2024cites this paper
• Effects of genetic variants of organic cation transporters on metformin response in newly diagnosed patients with type 2 diabetes

  2024cites this paper
• Genetic variation in organic cation transporters and considerations in drug development

  2023influential citation
• Progress in the Quantitative Assessment of Transporter-Mediated Drug–Drug Interactions Using Endogenous Substrates in Clinical Studies

  2023cites this paper
• Investigations with Drugs and Pesticides Revealed New Species- and Substrate-Dependent Inhibition by Elacridar and Imazalil in Human and Mouse Organic Cation Transporter OCT2

  2022cites this paper
• Transcriptional Regulation of Solute Carrier Drug Transporters

  2022cites this paper
• Special Section on New Era of Transporter Science: Unraveling the Functional Role of Orphan Transporters — Minireview Transcriptional Regulation of Solute Carrier Drug Transporters

  2022cites this paper
• Special Section on New Era of Transporter Science — Minireview Emerging Roles of the Human Solute Carrier 22 Family S

  2022cites this paper
• Emerging Roles of the Human Solute Carrier 22 Family

  2021cites this paper
• Expression and clinical significance of organic cation transporter family in glioblastoma multiforme

  2021cites this paper
• Codeine , morphine , and metformin : Common aspects of drug transport , drug-drug interactions , and pharmacogenetics

  2021cites this paper
• Neurotransmitter Transporters and Their Role in the Pharmacological Actions of Therapeutic and Abused Drugs

  2021cites this paper
• Organic Cation Transporters in Psychiatric Disorders.

  2021cites this paper